A comparative study of the clinical efficacy of nedocromil sodium and placebo: How does cromolyn sodium compare as an active control treatment?

Chest

Volumn 109, Issue 4, 1996, Pages 945-952

  Schwartz, Howard J ^a   Blumenthal, Malcolm ^a   Brady, Raymond ^a   Braun, Sheldon ^a   Lockey, Richard ^a   Myers, Debra ^a   Mansfield, Lyndon ^a   Mullarkey, Michael ^a   Owens, Gregory ^a   Ratner, Paul ^a   Repsher, Lawrence ^a   Van As, Andre ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

anti inflammatory; asthma; cromolyn sodium; Intal; nedocromil sodium; pulmonary function; quality of life; Tilade

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CROMOGLYCATE DISODIUM; NEDOCROMIL SODIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; THEOPHYLLINE;

ADULT; AGED; ALLERGIC ASTHMA; ARTICLE; BRONCHODILATATION; BRONCHOSPASM; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PEAK EXPIRATORY FLOW; PHARYNGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TASTE DISORDER;

EID: 9244221592     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.4.945     Document Type: Article

References (28)

1. Brogden KN, Sorkin RM. Nedocromil sodium: an updated review of its pharmacological properties and therapeutic efficacy in asthma. Drugs 1993; 45:693-715
2. Pearce FL, Al-Laith M, Bosman L, et al. Effects of sodium cromoglycate and nedocromil sodium on histamine secretions from mast cells from various locations. Drugs 1989; 37:37-43
3. Morton AR, Ogle SL, Fitch KD. Effects of nedocromil sodium, cromolyn sodium, and placebo in exercise-induced asthma. Ann Allergy 1992; 68:143-48
4. Richards R, Phillips GD, Holgate ST. Nedocromil sodium is more potent than sodium cromoglycate against AMP-induced bronchoconstriction in atopic asthmatic subjects. Clin Exp Allergy 1989; 19:285-91
5. Phillips GD, Scott VL, Richards R, et al. Effect of nedocromil sodium and sodium cromoglycate against bronchoconstriction induced by inhaled adenosine 5′-monophosphate. Eur Respir J 1989; 2:210-17
6. Crimi N, Palermo F, Oliveri R, et al. Comparative study of the effects of nedocromil sodium (4 mg) and sodium cromoglycate (10 mg) on adenosine-induced bronchoconstriction in asthmatic subjects. Clin Allergy 1988; 18:367-74
7. Dixon CMS, Fuller RW, Barnes PJ. Effect of nedocromil sodium on sulphur dioxide induced bronchoconstriction. Thorax 1987; 42:462-65
8. Altounyan REC, Cole M, Lee TB. Inhibition of sulphur dioxide-induced bronchoconstriction by nedocromil sodium and sodium cromoglycate in non-asthmatic atopic subjects. Eur J Respir Dis 1986; 69:274-76
9. Dixon CMS, Ind PW. Inhaled sodium metabisulfite induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br J Clin Pharmacol 1990; 30:371-76
10. Wright W, Zhang YG, Salome CM, et al. Effect of inhaled preservatives on asthmatic subjects: I. Sodium metabisulfite. Am Rev Respir Dis 1990; 141:1400-04
11. Del Bono L, Dente FL, Patalano F, et al. Protective effect of nedocromil sodium and sodium cromoglycate on bronchospasm induced by cold air. Eur J Respir Dis 1986; 69:268-70
12. Lal S, Bundgaard A, Beaumont G, et al. Nedocromil sodium is more effective than cromolyn sodium for the treatment of asthma. Chest 1993; 101:438-47
13. Orefice U, Struzzo P, Dorigo R, et al. Long-term treatment with sodium cromoglycate, nedocromil sodium and beclomethasone dipropionate reduces bronchial hyperresponsiveness in asthmatic subjects. Respiration 1992; 59:97-101
14. Creticos P, Norman P, Burk J, et al. The use of twice daily nedocromil sodium in the treatment of asthma. J Allergy Clin Immunol 1995; 95:829-36
15. Fink JN, Forman S, Slivers WS, et al. A double-blind study of the efficacy of nedocromil sodium in the management of asthma in patients using high doses of bronchodilators. J Allergy Clin Immunol 1994; 94:473-81
16. Condemi J, Pierantoni W, Wald J. Use of different spacers with nedocromil sodium: comparative improvement in taste. Ann Allergy 1995; 74:P59
17. Dahl R, Pedersen B. Influence of nedocromil sodium on the dual asthmatic reaction after allergen challenge: a double-blind placebo-controlled study. Eur J Respir Dis 1986; 69:263-65
18. Hegardt B, Pauwels R, Van der Straaten M. Inhibitory effect of KWO 2131, terbutaline and DSCG on the immediate and late allergen-induced bronchoconstriction. Allergy 1991; 36:115-22
19. Knottnerus I, Pelikan Z. The effects of cromolyn (DSCG), nedocromil, and (NS) budesonide (BUD) on the early (EAR) and late asthmatic response (LAR) inhaled before and after allergen challenge. J Allergy Clin Immunol 1994; 93:198
20. Pelikan Z, Knottnerus I. Inhibition of the late asthmatic response by nedocromil sodium administered more than two hours after allergen challenge. J Allergy Clin Immunol 1993; 92:19-28
21. Warringa RA, Mengelers HJJ, Maikoe T, et al. Inhibition of cytokine-primed eosinophil chemotaxis by nedocromil sodium. J Allergy Clin Immunol 1993; 91:802-09
22. Bruijnzeel PLB, Warringa RAJ, Kok PTM. Inhibition of platelet-activating factor-and zymogen-activated serum-induced chemotaxis of human neutrophils by nedocromil sodium, BN 52021 and sodium cromoglycate. Br J Pharmacol 1989; 97:1251-57
23. Davies RJ, Trigg CJ, Wang J, et al. The effects of long-term beclomethasone dipropionate on pathological changes in the bronchial mucosa of mild asthmatics. Am Rev Respir Dis 1993; 147:A841
24. Manolitsas ND, Wang JH, Devalia JL, et al. Regular albuterol, nedocromil sodium and bronchial inflammation in asthma. Am J Respir Crit Care Med 1995; 151:1925-30
25. Barnes PJ, Holgate ST, Laitinen LA, et al. Asthma mechanisms, determinants of severity and treatment: the role of nedocromil sodium. Clin Exp Allergy 1995; 25:771-87
26. Rebuck AS, Kesten S, Boulet LP, et al. A 3-month evaluation of the efficacy of nedocromil sodium in asthma: a randomized, double-blind, placebo-controlled trial of nedocromil sodium conducted by a Canadian multicentcr study group. J Allergy Clin Immunol 1990; 85:612-17
27. Wells A, Drennan O, Holst P, et al. Comparison of nedocromil sodium at two dosage frequencies with placebo in the management of chronic asthma. Respir Med 1992; 86:311-16
28. Kivity S, Fireman E, Greif J, et al. Effect of budesonide on bronchial hyperresponsiveness and pulmonary function in patients with mild to moderate asthma. Ann Allergy 1994; 72:333-36